Clinical trials getting harder to conduct

A recent report by the Tufts Center For the Study of Drug Development looks at how hard it is becoming to conduct clinical trials. Not only is it getting hard to get them off the ground, but, as we've seen in many articles throughout the Partnerships Blog, it's very hard to maintain patients throughout the process.

The article at the Boston Globe does point out that one of the reasons for this is the complexity of the trials that are now being treated. As the more rare and complex treatments get for certain diseases, the harder it will be find the right patient population. What do you think about the findings of the studies?